Enanta Pharmaceuticals Inc
ENTA
Revenue
17.97M
▲917.00k▲5.38%
3 Months ChangeAssets
398.82M
▼-14.74M▼-3.56%
3 Months ChangeLiabilities
249.91M
▲2.46M▲0.9954%
3 Months ChangeFree Cash Flow
-25.78M
▲13.02M▲33.56%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-08-07
Form 10-Q
ID: 0000950170-24-092714
2024-08-05
Form 8-K
ID: 0000950170-24-090722
2024-05-08
Form 10-Q
ID: 0000950170-24-055581
2024-05-06
Form 8-K
ID: 0000950170-24-053532
2024-03-12
Form 8-K
ID: 0000950170-24-029889
2024-02-08
Form 10-Q
ID: 0000950170-24-012796
2024-02-07
Form 8-K
ID: 0000950170-24-012186
2023-12-26
Form 8-K
ID: 0001193125-23-303014
2023-11-20
Form 8-K
ID: 0000950170-23-065087
2023-08-08
Form 10-Q
ID: 0000950170-23-039754